- Home
- DMF vs SCPH Comparison
DMF vs SCPH Comparison
Compare DMF & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMF
- SCPH
- Stock Information
- Founded
- DMF 1988
- SCPH 2013
- Country
- DMF United States
- SCPH United States
- Employees
- DMF N/A
- SCPH N/A
- Industry
- DMF Finance/Investors Services
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- DMF Finance
- SCPH Health Care
- Exchange
- DMF Nasdaq
- SCPH Nasdaq
- Market Cap
- DMF 152.2M
- SCPH 173.6M
- IPO Year
- DMF N/A
- SCPH 2017
- Fundamental
- Price
- DMF $7.27
- SCPH $2.26
- Analyst Decision
- DMF
- SCPH Strong Buy
- Analyst Count
- DMF 0
- SCPH 3
- Target Price
- DMF N/A
- SCPH $14.00
- AVG Volume (30 Days)
- DMF 60.7K
- SCPH 658.4K
- Earning Date
- DMF 01-01-0001
- SCPH 05-13-2025
- Dividend Yield
- DMF 2.66%
- SCPH N/A
- EPS Growth
- DMF N/A
- SCPH N/A
- EPS
- DMF 0.15
- SCPH N/A
- Revenue
- DMF N/A
- SCPH $36,332,000.00
- Revenue This Year
- DMF N/A
- SCPH $114.00
- Revenue Next Year
- DMF N/A
- SCPH $77.45
- P/E Ratio
- DMF $45.13
- SCPH N/A
- Revenue Growth
- DMF N/A
- SCPH 167.28
- 52 Week Low
- DMF $5.37
- SCPH $2.20
- 52 Week High
- DMF $6.79
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- DMF 58.25
- SCPH 27.64
- Support Level
- DMF $7.13
- SCPH $2.20
- Resistance Level
- DMF $7.29
- SCPH $3.08
- Average True Range (ATR)
- DMF 0.06
- SCPH 0.21
- MACD
- DMF -0.00
- SCPH -0.07
- Stochastic Oscillator
- DMF 76.00
- SCPH 6.06
About DMF BNY Mellon Municipal Income Inc.
BNY Mellon Municipal Income, Inc. is a non-diversified closed-end management investment company. Its investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. The fund invests in municipal obligations that are rated investment grade and have maturities of less than one year. The company targets to invest in the sector such as education, pre-refunded muni, utility, transportation, healthcare, special tax, state/territory general obligations, industry revenue, and pollution control.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.